Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects

BACKGROUND: Analytical data suggesting that immunoglobulin given intramuscularly (IGIM) may have reduced protection against hepatitis A virus (HAV) infection led to an update in the recommended IGIM dose (0.2 ml/kg). METHODS: This prospective, open-label, single-arm clinical study evaluated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Kankam, Martin, Griffin, Rhonda, Price, Jeffrey, Michaud, Josée, Liang, Wei, Llorens, Mariona Bassas, Sanz, Ana, Vince, Bradley, Vilardell, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467477/
https://www.ncbi.nlm.nih.gov/pubmed/32301062
http://dx.doi.org/10.1007/s12325-020-01327-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467477/
https://www.ncbi.nlm.nih.gov/pubmed/32301062
http://dx.doi.org/10.1007/s12325-020-01327-9

Ejemplares similares